Tagline
New Biomarker Test Revolutionizes Inflammatory Skin Disease Diagnosis
Inflammatory skin disease research is undergoing a "translational revolution," yet clinical practice still lags behind laboratory discoveries.

Bradford Teaching Hospitals is to take part in trailblazing AI project which detects skin cancer earlier https://www.bradfordhospitals.nhs.uk/bradford-teaching-hospitals-is-to-take-part-in-trailblazing-ai-project-which-detects-skin-cancer-earlier/
Hälsoskanningsstartupen Neko Health, grundad av Spotifys medgrundare Daniel Ek, öppnar sitt första amerikanska kontor den 24 september – mitt i Soho-distriktet i Manhattan.
Neko Health grundades av Spotify-vd:n Daniel Ek och Hjalmar Nilsonne, som är bolagets vd. Företaget har utvecklat en egenutvecklad teknik för kroppsskanning som kombineras med blodprover och data från träningsenheter för att bedöma en persons hälsa. Sedan tidigare har startupen verksamhet i Storbritannien och Sverige. https://www.breakit.se/artikel/47122/daniel-eks-halsobolag-neko-health-oppnar-pa-lyxiga-adressen
Tagline
Immunosuppressed patients with non-melanoma skin cancer are not missing the key cancer-fighting immune cells found in immunocompetent patients, but those cells – known as macrophages – have lost the ability to communicate effectively. This new understanding may help researchers develop new treatment approaches for these aggressive skin cancers.
Understanding exactly how the immune cells are altered could help researchers develop methods for preventing or reversing those changes, opening new therapeutic options for these patients.
With a flash of light, 2,000 photographs are taken of my body, in the hope of capturing every mark, freckle and mole to analyse for different skin cancers.
This full-body scan is happening at a sci-fi-style clinic in Manchester city centre, with me wearing a dressing gown and hexagon-shaped rubber slippers. The millions of data points collected will create a 3D avatar of my body using AI.
Hjalmar Nilsonne, one of the founders of Neko Health, wants to see this preventative treatment available for every individual, not just those who can afford to pay for it.
